Financial results: Avecho; Elixinol; Epsilon; Creso Pharma by Steve Jones May 2, 2023May 3, 2023 Biotech firm Avecho has told the Australian Securities Exchange (ASX) that it has no concerns over […]
Second trial flagged by Ecofibre in bid to get S3 product over the line by Steve Jones February 1, 2023February 1, 2023
Blow for NZ industry as over-the-counter CBD is knocked back by Steve Jones December 5, 2022December 6, 2022
Bod’s S3 registration candidate to go on sale through Special Access Scheme by Steve Jones June 27, 2022June 28, 2022
Patience the watchword as companies line up to put S3 visions to the test by Steve Jones March 30, 2021April 1, 2021